MYCIO Wealth Partners’s Agios Pharmaceuticals AGIO Stock Holding History

MYCIO Wealth Partners’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-500	Closed	-$35K	–	717
2015 Q3	$35K	Hold	500	–	–	0.01%	343
2015 Q2	$56K	Hold	500	–	–	0.01%	281
2015 Q1	$47K	Buy	+500	New	+$56K	0.01%	289
2014 Q4	–	Sell	-500	Closed	-$31K	–	625
2014 Q3	$31K	Buy	+500	New	+$21.6K	0.01%	308

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MYCIO Wealth Partners's AGIO Position: Q4 2015 in Review

MYCIO Wealth Partners sold out of Agios Pharmaceuticals (AGIO) in Q4 2015, closing a stake of 500 shares — an estimated $35K sold.

MYCIO Wealth Partners first reported a position in AGIO in Q3 2014 and held it in 4 quarters. The position peaked at $56K in Q2 2015. 145 funds tracked by Wall St. Rank hold AGIO as of Q4 2015.

MYCIO Wealth Partners reported no remaining Agios Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
MYCIO Wealth Partners sold 500 Agios Pharmaceuticals shares in Q4 2015, an estimated $35K.
MYCIO Wealth Partners first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 4 quarters.
MYCIO Wealth Partners's Agios Pharmaceuticals position peaked at $56K in Q2 2015.
145 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2015.

Based on MYCIO Wealth Partners's 13F filing for Q4 2015, filed 5 Feb 2016.